Back to Treatments

Treatment

Galcanezumab

1
Conditions
3
Trials
1,200
Participants
85%
Average Safety

Condition Evidence

Cluster Headache

3 trials · 1,200 participants

85% effectiveness · 85% safety
Galcanezumab | DFDA